kynurenine has been researched along with Tauopathies in 2 studies
Kynurenine: A metabolite of the essential amino acid tryptophan metabolized via the tryptophan-kynurenine pathway.
kynurenine : A ketone that is alanine in which one of the methyl hydrogens is substituted by a 2-aminobenzoyl group.
Tauopathies: Neurodegenerative disorders involving deposition of abnormal tau protein isoforms (TAU PROTEINS) in neurons and glial cells in the brain. Pathological aggregations of tau proteins are associated with mutation of the tau gene on chromosome 17 in patients with ALZHEIMER DISEASE; DEMENTIA; PARKINSONIAN DISORDERS; progressive supranuclear palsy (SUPRANUCLEAR PALSY, PROGRESSIVE); and corticobasal degeneration.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Majerova, P | 1 |
| Olesova, D | 1 |
| Golisova, G | 1 |
| Buralova, M | 1 |
| Michalicova, A | 2 |
| Vegh, J | 1 |
| Piestansky, J | 1 |
| Bhide, M | 1 |
| Hanes, J | 1 |
| Kovac, A | 2 |
| Galba, J | 1 |
| Parrak, V | 1 |
| Novak, M | 1 |
2 other studies available for kynurenine and Tauopathies
| Article | Year |
|---|---|
Analog of kynurenic acid decreases tau pathology by modulating astrogliosis in rat model for tauopathy.
Topics: Animals; Gliosis; Kynurenic Acid; Kynurenine; Neurodegenerative Diseases; Neuroprotective Agents; Ra | 2022 |
Quantitative analysis of phenylalanine, tyrosine, tryptophan and kynurenine in rat model for tauopathies by ultra-high performance liquid chromatography with fluorescence and mass spectrometry detection.
Topics: Animals; Chromatography, High Pressure Liquid; Disease Models, Animal; Humans; Kynurenine; Phenylala | 2016 |